Screening For Liver Cancer Market – Blood-Based Biomarkers Revolutionizing Early Detection
Market Overview The screening for liver cancer market is revolutionizing as blood-based biomarker panels emerge to complement or potentially replace imaging-based surveillance in select populations. Novel multi-cancer early detection assays, circulating tumor DNA analysis, and enhanced alpha-fetoprotein variants are demonstrating sensitivity for hepatocellular carcinoma detection at earlier...
0 Comments 0 Shares 181 Views 0 Reviews